TABLE 2.
Comparison of clinical characteristics between circ_0018289 high expression patients and circ_0018289 low expression patients
| Items | Circ_0018289 expression | P value | |
|---|---|---|---|
| High (n = 96) | Low (n = 96) | ||
| Age (y), No. (%) | .559 | ||
| <45 y | 43 (44.8) | 39 (40.6) | |
| ≥45 y | 53 (55.2) | 57 (59.4) | |
| HPV status, No. (%) | .590 | ||
| Negative | 21 (21.9) | 18 (18.8) | |
| Positive | 75 (78.1) | 78 (81.2) | |
| Histological type, No. (%) | .421 | ||
| Adenosquamous carcinoma | 7 (7.3) | 3 (3.1) | |
| Adenocarcinoma | 19 (19.8) | 21 (21.9) | |
| Squamous carcinoma | 70 (72.9) | 72 (75.0) | |
| Pathological grade, No. (%) | .218 | ||
| G1 | 27 (28.1) | 28 (29.1) | |
| G2 | 34 (35.4) | 45 (46.9) | |
| G3 | 35 (36.5) | 23 (24.0) | |
| Tumor size, No. (%) | .009 | ||
| <4 cm | 45 (46.9) | 63 (65.6) | |
| ≥4 cm | 51 (53.1) | 33 (34.4) | |
| Lymph node metastasis, No. (%) | .005 | ||
| No | 71 (74.0) | 86 (89.6) | |
| Yes | 25 (26.0) | 10 (10.4) | |
| FIGO stage, No. (%) | .005 | ||
| I | 50 (52.1) | 69 (71.9) | |
| IIA | 46 (47.9) | 27 (28.1) | |
Comparison was determined by chi‐square test or Wilcoxon rank sum test.
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus.